Medcaw Investments Plc - Directorate Change

3rd March 2023 

Medcaw Investments Plc - 13078596 
(“Medcaw Investments” or the “Company”) 

Board Changes 

Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, announces that it has appointed Mr Charles Ainslie (“Charlie”) Wood and Marcus Yeoman as Non-executive Directors of the Company with immediate effect, furthermore Daniel Maling and Fungai Ndoro have stepped down from the Board of the Company to focus on other projects. The Company would like to thank Daniel and Fungai for their contribution whilst on the Board and would like to wish them all the best in their future endeavours. All director fees will be deferred until the transaction between Medcaw and ATC is completed. Marcus Yeoman holds 0.18% and Charles Wood holds 6.16% of Medcaw Investments.  

Charlie Wood is a highly experienced senior corporate finance executive with wide ranging international and capital markets experience. Mr Wood is a Partner of Orana Corporate LLP, a London based FCA regulated corporate advisory and accounting practise working with innovative fast growth companies. In addition, Mr Wood holds various non-executive directorships in listed and private companies across natural resources, technology and FMCG. 

Marcus Yeoman is Chairman and Non-Executive director number of private companies which have engaged him principally to assist them with their growth strategies. His early career started with the formation of three companies in IT infrastructure and distribution, after which he moved into small company broking and corporate work with Rathbone Stockbrokers Limited and Cheviot Capital (Nominees) Limited. In 2003, Marcus established Springtime Consultants Ltd and has been acting as a consultant or Non-Executive Director to a number of listed companies and SME ventures over the 20 years. 

Further disclosures on Mr Wood and Marcus Yeoman as required pursuant to the FCA LR 9.6.11 Rulebook are included in the Appendix below. 

This announcement contains inside information for the purposes of UK Market Abuse Regulation. 

The persons who arranged the release of this information are the Directors of the Company. 

*** ENDS *** 

Enquiries: 

Medcaw Investments Plc +44 (0)203 918 8797 

Sarah Cope, Executive Chairperson  

Arden Partners Plc       +44 (0) 2076 145 926 

Ruari McGirr  

Alexandra Campbell-Harris 

Appendix 

The following information is disclosed in respect of Mr Charles Ainslie Wood (age 48) pursuant to pursuant to Rule 4.9 of the FCA LR 9.6.11 Rulebook. All information is as at the date of this announcement. 

Current Directorships / Partnerships:   

Ainslie Capital Limited                 

Critical Flow Tech UK Ltd               

ETI Ventures plc                        

Hyperion Resources Ltd (prev. Hyperion CJT Investments Ltd 

Global Corporation) 

Leintwardine pty Ltd                    

Longview Energy Limited                 

Medcaw Technologies Limited             

Metallea Limited (prev. Hyperion        

Orana Corporate LLP                     

Supernatural Food Limited               

Tasmania Vodka Ltd                      

Woodell Investments pty Ltd             

Past Directorships / Partnerships (within the last five years): 

Basin Energy One plc 

Attis Oil and Gas Limited 

Black Swan Resources plc 

Brand Sheild Systems plc (prev. Two Shields Investments plc) 

Deloro Energy LLP 

East Star Resources plc 

Euro SI ltd 

Helium One (UK) Limited (prev. Attis Oil & Gas (UK) Limited)  

Helium Ventures plc 

Metals One plc 

Suboceanic plc 

Suboceanic Group 

Thrivanta Investments plc 

Zarmandan Gold Limited 

Mr Wood was a director of Euro SI Ltd which was dissolved by way of a creditors’ voluntary wind-up at the time of or in the 12 months following his resignation as a director. 

Mr Wood was a director of Commodities Finance Limited that was dissolved via a voluntary strike-off at the time of or in the 12 months following his resignation as a director. 

Mr Wood has an interest in 1,056,000 ordinary shares and a warrant to subscribe for 844,800 ordinary shares in the Company, totalling 6.16% of holdings. 

The following information is disclosed in respect of Mr Marcus Yeoman (age 59) pursuant to pursuant to the FCA LR 9.6.11 Rulebook. All information is as at the date of this announcement. 

Current Directorships / Partnerships:   

Tower Green Holding (14254478)  

Kipling House Investments Limited (13498851) 

Widetek Limited (12273039) 

Hancock Scotland Limited (SC591337)Springtime Consultants(04657744) 

Storyboard Assets Plc (06436259) 

Peter Nicholson Films (07353933)Oneline Films Ltd (09133685) 

Past Directorships / Partnerships (within the last five years): 

Online Films Ltd (09133685) 

R4E Limited(07841406) 

Newman Displays Limited (02250991) 

Dewynters Limited (00197585) 

Miroma Set Limited (02725009) 

Melrose and Morgan (05085202) 

Intosol Holdings Plc (10806039) 

Mr Yeoman has an interest in 30,900 ordinary shares in the company, totalling 0.18% of holdings.